Immunoassay accounted for 26% share of the IVD market in 2013. The recent technological development focuses more on detecting one or several proteins in a patient’s blood or serum. The growth of the immunoassays market will primarily be dependent on the development of novel assays in prime areas, such as cardiology, oncology, and various autoimmune diseases, as these novel assays will help companies gain a competitive edge.
The rising automation trend is a major driver for the growth of immunoassay market as it helps reduce the cost of labor, which accounts for around 50% of the total cost of a test. There has been an increase in the awareness of health and fitness across the globe and hence, most people are now undergoing routine tests regularly.
The Centers for Medicare & Medicaid Services (CMS) has estimated that healthcare spending in the U.S. is expected to grow from $2.7 trillion in 2011 to about $4.6 trillion in 2018, at a CAGR of 6.8% for the given period. Similarly, in emerging countries, awareness and an increasing middle-class population, with a more disposable income to spend on healthcare, will be a driving force for the growth of this market.
The report ‘North American Immunoassay Market forecast for 2018’ analyzes the market by segments such as reagents and end instruments.
The North America commanded the largest share of 42% in the global immunoassay market at $5248.2 million in 2013, and is expected to reach $7563.2 million by 2018, at a CAGR of 8% from 2013 to 2018.
The report also provides an extensive competitive landscaping of companies operating in immunoassay market. The major players immunoassay market are Siemens (Germany), Roche Diagnostics (Switzerland), Abbott Laboratories (U.S.), Danaher Corporation (U.S.), Ortho Clinical Diagnostics (U.S.), and bioMerieux SA (France).
Segment and country-specific company shares, news & deals, mergers and acquisitions, segment specific pipeline products, product approvals, and product recalls of the major companies have been detailed in this report.
Along with the market data, you can also customize MMM assessments that meet your company’s specific needs. Customize to get comprehensive industry standard and deep dive analysis of the following parameters:
- Unmet needs, revenue pockets, and potential areas for expansion for immunoassay market
- Comprehensive review of key component providers, analyzers, and test kit providers for immunoassay market
Current and Emerging Products
- Analysis of current and emerging immunoassay and immunodiagnostic tests
- Review of current instrumentation technologies in immunoassay
- Pricing trend of immunoassay tests
- Usage pattern (in-depth trend analysis) of products (segment wise)
- Product matrix which gives a detailed comparison of product portfolio of each company mapped at country and sub-segment level
- End-user adoption rate analysis of the products (segment wise and country wise)
- Comprehensive coverage of product approvals, pipeline products, and product recalls
Brand/Product Perception Matrix
- Comprehensive study of customers perception and behavior through our inbuilt social connect tool checking the virility and tonality of blogs
- Analysis of overall brand usage and familiarity and brand advocacy distribution (detractor/neutral/familiar)
Alternative Products: Impact analysis
MMM’s healthcare decision making quadrant is an innovative and useful quadrant for vendors who wish to analyze the potential growth markets based on parameters like patient dynamics (patient pool, epidemiology of disease, preference towards surgeries/alternative therapies) and macroeconomic indicators (number of hospitals and orthopedic clinics, reimbursement scenario, diagnosis rate, treatment rate and healthcare expenditure).
1.1 Objective of the study
1.2 Market Definitions
1.3 Market Segmentation & Aspects Covered
1.4 Research Methodology
1.4.1 Assumptions (Market Size, Forecast, etc)
2 Executive Summary
3 Market Overview
Please fill in the form below to receive a free copy of the Summary of this Report
Please visit http://www.micromarketmonitor.com/custom-research-services.html to specify your custom Research Requirement
North America In Vitro Diagnostics
In 2013, the Americas had the largest market, a 42% share of the Global IVD market, followed by Europe with a 31% share. However, the BRIC countries represent the fastest-growing markets due to the economic growth, the rising number of chronic diseases, and an increasing awareness about the use of IVD tests to control the spread of diseases. Moreover, the economic slowdown, pricing pressures, and high competition in mature countries will compel companies to focus on emerging markets. The report “North American In Vitro Diagnostics Market forecast for 2018 “analyzes the market by 5 segments such as reagents, instruments, techniques, applications and end-users.
Europe In Vitro Diagnostics
In 2013, the Americas had the largest market, a 42% share of the European IVD market, followed by Europe with a 31% share. However, the BRIC countries represent the fastest-growing markets due to the economic growth, the rising number of chronic diseases, and an increasing awareness about the use of IVD tests to control the spread of diseases. Moreover, the economic slowdown, pricing pressures, and high competition in mature countries will compel companies to focus on emerging markets. The report “European In Vitro Diagnostics Market forecast for 2018 “analyzes the market by 5 segments such as reagents, instruments, techniques, applications and end-users. Germany commanded the largest share in European IVD market.
Asia In Vitro Diagnostics
Asian IVD market is growing in double digit and will continue to grow in future. China commanded the largest share in Asian IVD market. The report “Asian In Vitro Diagnostics Market forecast for 2018 “analyzes the market by 5 segments such as reagents, instruments, techniques, applications and end-users.